SAN DIEGO, March 2 /PRNewswire-FirstCall/ -- Orexigen® Therapeutics, Inc. (NASDAQ:OREX) , a biopharmaceutical company focused on the treatment of obesity, today ...
NEWTON, Mass., Dec. 6, 2021 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced the appointment of ...
Peter Honig's most active month to dispose stocks was the month of February. 2015 saw Peter Honig paying a total of $101,010.00 for 69,700 shares, this is the most they've acquired in one year. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results